Page 268 - Accelerator Application Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accelerator application development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accelerator Application Development Today - Breaking & Trending Today

Payer Insights Program Highlights How Payers and Tech Partners Are Thinking About AI, Health Equity, and the Consumer Experience

HLTH 2023 introduced a new program focused on technology trends for and perspectives from payers in a series of conversations around AI, health equity and healthcare innovation. ....

United States , Eugene Sayan , Kaiser Permanente , Amir Azarbad , Amir Azerbad , Arundhati Parmar , Ainsley Maclean , Fred Turner , Payer Insights Program , Good At Payer Insights Program , Payer Insights , Medcity News , Softheon Founder , Chief Medical Information Officer , American Board , Artificial Intelligence , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System ,

Why the AMA President Thinks Scope of Practice Expansions Are a 'Terrible Idea'

To address the growing physician shortage, some people argue that the scope of practice should be expanded for skilled healthcare professionals like nurse practitioners and pharmacists. American Medical Association President Dr. Jesse Ehrenfeld said this is a “terrible idea.” He argued that throwing other professionals into physicians' roles will have poor ramifications of patient safety. In his view, the industry should focus on uplifting strong interprofessional care teams. ....

United States , Jesse Ehrenfeld , Las Vegas , American Medical Association , American Medical Association President , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery , Aser Surgery , Ealth And Wellness , Mployee Wellness Programs , Hanghai Innovation Center ,

Is Medicare Advantage a Failed Experiment? Experts Debate

Enrollment in Medicare Advantage is increasing, but the program has been drawing scrutiny from the government. Can the program be saved? One expert believes Medicare Advantage is a failed experiment. Another thinks that while the program has its flaws, it shows tremendous potential. ....

Sachin Jain , Rick Gilfillan , Las Vegas , Health Plan , Trinity Health System , Medicare Advantage , Medicaid Innovation , Subsidized Medicare Advantage , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery , Aser Surgery ,

Novo Nordisk's Star Diabetes & Obesity Drug Shows Promise in Kidney Disease

A study testing Novo Nordisk's semaglutide in chronic kidney disease is ending early after an interim analysis met efficacy goals. Detailed results are not yet available, but they could support expanding use of the GLP-1 agonist, which is far and away Novo Nordisk’s top-selling product. ....

United States , Novo Nordisk , Journal Of The American Medical Association , American Medical Association , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery , Aser Surgery , Ealth And Wellness , Mployee Wellness Programs , Hanghai Innovation Center , R D ,

FDA Rejection Is a Delay, Not a Detour for Alnylam's Aim to Treat Heart Disorder

Despite an affirmative FDA advisory committee vote, the agency declined to approve Alnylam Pharmaceuticals’ Onpattro for treating the heart complications caused by a rare, inherited protein disorder. But Alnylam has other drugs candidates for the disease, including one expected to post Phase 3 data in the first half of 2024. ....

United States , United Kingdom , Bridgebio Pharma , Yvonne Greenstreet , William Blair , Myles Minter , European Society Of Cardiology , Alnylam Pharmaceuticals , European Society , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery ,